Medidata Solutions Inc  

(Public, NASDAQ:MDSO)   Watch this stock  
Find more results for David Wilhite�
47.40
+0.86 (1.85%)
Sep 2 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 46.36 - 47.50
52 week 32.10 - 68.21
Open 46.81
Vol / Avg. 362,090.00/562,477.00
Mkt cap 2.51B
P/E 411.82
Div/yield     -
EPS 0.12
Shares 54.03M
Beta 0.64
Inst. own 105%
Oct 22, 2014
Q3 2014 Medidata Solutions Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 9, 2014
Medidata Solutions Inc at Deutsche Bank Technology Conference - 2:00PM EDT - Add to calendar
Sep 3, 2014
Medidata Solutions Inc at Citi Global Technology Conference - 10:15AM EDT - Add to calendar
Aug 5, 2014
Medidata Solutions Inc at Needham Interconnect Conference
Jul 29, 2014
Q2 2014 MEDIDATA SOLUTIONS INC Earnings Release
Jul 29, 2014
Q2 2014 Medidata Solutions Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 2.76% 6.02%
Operating margin 8.58% 8.63%
EBITD margin - 11.13%
Return on average assets 1.63% 4.18%
Return on average equity 4.01% 9.06%
Employees 923 -
CDP Score - -

Address

350 Hudson St Fl 9
NEW YORK, NY 10014-4535
United States - Map
+1-212-9181800 (Phone)
+1-212-9181818 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Medidata Solutions, Inc. (Medidata) is a global provider of software-as-a-service (SaaS), clinical technology solutions. Medidata offers Medidata Rave, is a platform that integrates electronic data capture (EDC), with a clinical data management system (CDMS), in a solution that replaces traditional paper-based methods of capturing and managing clinical data. Medidata Rave offers a platform enabling sponsors to manage complex trials. Medidata customers are pharmaceutical, biotechnology and medical device companies, academic institutions, contract research organizations (CROs), and other organizations engaged in clinical trials to bring medical products and treatments to market and explore indications for existing medical products. Medidata Rave�s intuitive, user-friendly Internet-based technology facilitates rapid adoption by investigators, sponsors and CROs. On July 1, 2011, the Company acquired Clinical Force Limited (Clinical Force).

Officers and directors

Tarek A. Sherif Chairman of the Board, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
Glen M. de Vries President, Director
Age: 41
Bio & Compensation  - Reuters
Cory A. Douglas Chief Financial Officer, Executive Vice President
Age: 43
Bio & Compensation  - Reuters
Steven F. Wilhite Executive Vice President, Chief Marketing Officer
Age: 61
Bio & Compensation  - Reuters
Michael I. Otner Executive Vice President, General Counsel, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Eileen M. Schloss Executive Vice President - Human Resources
Age: 60
Bio & Compensation  - Reuters
Steven I. Hirschfeld Executive Vice President - Chief Value Officer
Age: 51
Bio & Compensation  - Reuters
Alan V. Mateo Executive vice president - field operations
Age: 51
Bio & Compensation  - Reuters
Bryan C. Spielman Executive Vice President - Strategy and Corporate Development
Age: 47
Bio & Compensation  - Reuters
David Colistra Senior Vice President, Chief Accounting Officer
Bio & Compensation  - Reuters